Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections.

Author(s): Kikano G

Affiliation(s): Department of Family Medicine, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA. gek@case.edu

Publication date & source: 2009-05, Postgrad Med., 121(3):173-5.

Publication type: Comment; Comparative Study; Randomized Controlled Trial

Acute bacterial respiratory infections (ABRIs) require treatment with antibiotics. Although antibiotics may address the underlying pathogenic factors, over-the-counter (OTC) agents can play an adjuvant role in relieving mucus-related symptoms. This complimentary role contributes to the healing process and is supported by current clinical guidelines.